Chemoinformaics analysis of Methyl 3-hydroxy-3-methylbutanoate
| Molecular Weight | 132.159 | nRot | 2 |
| Heavy Atom Molecular Weight | 120.063 | nRig | 11 |
| Exact Molecular Weight | 132.079 | nRing | 0 |
| Solubility: LogS | -3.776 | nHRing | 0 |
| Solubility: LogP | 3.138 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.4275 |
| nHD | 1 | BPOL | 14.6425 |
| QED | 0.72 |
| Synth | 2.265 |
| Natural Product Likeliness | 0.654 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.457 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.666 |
| MDCK | 0.0000245 |
| BBB | 0.426 |
| PPB | 0.951011 |
| VDSS | 2.753 |
| FU | 0.0545087 |
| CYP1A2-inh | 0.993 |
| CYP1A2-sub | 0.892 |
| CYP2c19-inh | 0.927 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.153 |
| CYP2c9-sub | 0.904 |
| CYP2d6-inh | 0.92 |
| CYP2d6-sub | 0.935 |
| CYP3a4-inh | 0.782 |
| CYP3a4-sub | 0.425 |
| CL | 14.218 |
| T12 | 0.597 |
| hERG | 0.035 |
| Ames | 0.074 |
| ROA | 0.014 |
| SkinSen | 0.916 |
| Carcinogencity | 0.931 |
| EI | 0.882 |
| Respiratory | 0.797 |
| NR-Aromatase | 0.117 |
| Antiviral | No |
| Prediction | 0.967479 |